ABO blood type incompatible kidney transplantation without splenectomy prepared with plasma exchange and rituximab. 2008

T Chikaraishi, and H Sasaki, and H Tsutsumi, and S Miyano, and R Nakazawa, and T Nakano, and K Kitajima, and H Kudo, and T Takahashi, and Y Sato, and K Kimura
Department of Urology, St. Marianna University, Kawasaki, Kanagawa, Japan. T.chikaraishi@gmail.com

We have designed a protocol for ABO-incompatible kidney transplantations based on preoperative plasmapheresis with a tacrolimus/mycophenolate mofetil/methylprednisolone/basiliximab protocol using low-dose rituximab (200 mg/body) instead of splenectomy to prevent antibody-mediated acute rejection. Eight patients successfully received transplants with this protocol. The titers of anti-A and -B antibodies as well as the number of CD20(+) cells were readily maintained at a low level posttransplantation. There were no side effects. All patients have renal transplant function with a follow-up of 1-34 months.

UI MeSH Term Description Entries
D007155 Immunologic Factors Biologically active substances whose activities affect or play a role in the functioning of the immune system. Biological Response Modifier,Biomodulator,Immune Factor,Immunological Factor,Immunomodulator,Immunomodulators,Biological Response Modifiers,Biomodulators,Factors, Immunologic,Immune Factors,Immunological Factors,Modifiers, Biological Response,Response Modifiers, Biological,Factor, Immune,Factor, Immunological,Factors, Immune,Factors, Immunological,Modifier, Biological Response,Response Modifier, Biological
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007518 Isoantibodies Antibodies from an individual that react with ISOANTIGENS of another individual of the same species. Alloantibodies
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009679 Nuclear Family A family composed of spouses and their children. Daughters,Sons,Daughter,Families, Nuclear,Family, Nuclear,Nuclear Families,Son
D010951 Plasma Exchange Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions. Exchange, Plasma,Exchanges, Plasma,Plasma Exchanges
D010956 Plasmapheresis Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use. Double Filtration Plasmapheresis,Therapeutic Immunoadsorption,Therapeutic Plasma Adsorption,Therapeutic Plasmapheresis,Adsorption, Therapeutic Plasma,Adsorptions, Therapeutic Plasma,Double Filtration Plasmaphereses,Filtration Plasmapheresis, Double,Immunoadsorption, Therapeutic,Plasma Adsorption, Therapeutic,Plasmaphereses,Plasmapheresis, Double Filtration,Plasmapheresis, Therapeutic,Therapeutic Immunoadsorptions,Therapeutic Plasma Adsorptions,Therapeutic Plasmaphereses
D001787 Blood Group Incompatibility An antigenic mismatch between donor and recipient blood. Antibodies present in the recipient's serum may be directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984). ABO Compatibility,ABO Incompatibility,Blood Group ABO Incompatibility,Blood Type Incompatibility,Rh Compatibility,Rh Incompatibility,ABO Compatibilities,ABO Incompatibilities,Blood Group Incompatibilities,Blood Type Incompatibilities,Compatibility, ABO,Compatibility, Rh,Incompatibilities, Blood Group,Incompatibility, ABO,Incompatibility, Blood Group,Incompatibility, Blood Type,Incompatibility, Rh,Rh Compatibilities,Rh Incompatibilities
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine

Related Publications

T Chikaraishi, and H Sasaki, and H Tsutsumi, and S Miyano, and R Nakazawa, and T Nakano, and K Kitajima, and H Kudo, and T Takahashi, and Y Sato, and K Kimura
September 2006, Transplantation,
T Chikaraishi, and H Sasaki, and H Tsutsumi, and S Miyano, and R Nakazawa, and T Nakano, and K Kitajima, and H Kudo, and T Takahashi, and Y Sato, and K Kimura
October 2005, Transplantation proceedings,
T Chikaraishi, and H Sasaki, and H Tsutsumi, and S Miyano, and R Nakazawa, and T Nakano, and K Kitajima, and H Kudo, and T Takahashi, and Y Sato, and K Kimura
January 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
T Chikaraishi, and H Sasaki, and H Tsutsumi, and S Miyano, and R Nakazawa, and T Nakano, and K Kitajima, and H Kudo, and T Takahashi, and Y Sato, and K Kimura
December 2003, Transplantation,
T Chikaraishi, and H Sasaki, and H Tsutsumi, and S Miyano, and R Nakazawa, and T Nakano, and K Kitajima, and H Kudo, and T Takahashi, and Y Sato, and K Kimura
December 2015, Journal of clinical apheresis,
T Chikaraishi, and H Sasaki, and H Tsutsumi, and S Miyano, and R Nakazawa, and T Nakano, and K Kitajima, and H Kudo, and T Takahashi, and Y Sato, and K Kimura
August 2003, Transplantation,
T Chikaraishi, and H Sasaki, and H Tsutsumi, and S Miyano, and R Nakazawa, and T Nakano, and K Kitajima, and H Kudo, and T Takahashi, and Y Sato, and K Kimura
July 2012, Annals of laboratory medicine,
T Chikaraishi, and H Sasaki, and H Tsutsumi, and S Miyano, and R Nakazawa, and T Nakano, and K Kitajima, and H Kudo, and T Takahashi, and Y Sato, and K Kimura
January 2011, Clinical transplantation,
T Chikaraishi, and H Sasaki, and H Tsutsumi, and S Miyano, and R Nakazawa, and T Nakano, and K Kitajima, and H Kudo, and T Takahashi, and Y Sato, and K Kimura
June 2017, Transplantation,
T Chikaraishi, and H Sasaki, and H Tsutsumi, and S Miyano, and R Nakazawa, and T Nakano, and K Kitajima, and H Kudo, and T Takahashi, and Y Sato, and K Kimura
December 2017, The Journal of international medical research,
Copied contents to your clipboard!